|
High Throughput 3D Cell Assay for Metastatic Prostate Cancer
|
3R41CA165463-01A1S1
|
$34,628
|
TAKAYAMA, SHUICHI
|
3D BIOMATRIX, INC.
|
|
Integrated Photoacoustic Ultrasound Real-time Imaging for Brachytherapy Treatment
|
1R43CA180561-01
|
$177,408
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-05
|
$1,806,651
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-40S1
|
$75,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting Cancer Cells with Functionalized Nanoparticle Libraries
|
5R21CA157366-03
|
$165,492
|
LEVY, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
|
5U01CA158431-03
|
$308,265
|
Ostrer, Harry
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
3U10CA014958-38S1
|
$144,167
|
Sparano, Joseph
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
1U10CA176879-01
|
$558,366
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Community Clinical Oncology Program
|
5U10CA037422-26
|
$2,811,894
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-37
|
$14,566,378
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
5U24CA114734-08
|
$977,658
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
|
5U01CA141497-05
|
$541,659
|
Ittmann, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
|
5R01CA128932-05
|
$290,421
|
MARKAVERICH, BARRY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
DNA Repair and Replication Re-start in vivo
|
5R01CA085777-10
|
$274,085
|
Rosenberg, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mesenchymal Derived Growth Factors in Prostatic Cancer
|
5R01CA058093-20
|
$246,042
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
|
3U01CA167234-02S1
|
$103,544
|
Sreekumar, Arun
|
BAYLOR COLLEGE OF MEDICINE
|
|
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
|
5U01CA167234-02
|
$304,688
|
Sreekumar, Arun
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND
|
5R00CA151293-04
|
$227,038
|
Zhang, Xiang
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
1P01CA163227-01A1
|
$2,183,516
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
3U10CA080775-14S1
|
$43,980
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular basis of androgen receptor mediated gene transcriptional repression
|
5K99CA166507-02
|
$134,946
|
Cai, Changmeng
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Androgen Receptor Regulation by Phosphorylation
|
5R00CA135592-05
|
$227,037
|
Chen, Shaoyong
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-05
|
$634,348
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
PTEN in ontogenesis and tumor suppression
|
2R01CA082328-16
|
$336,229
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-09
|
$311,080
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The Co-Clinical Trial Project
|
5U01CA141457-05
|
$695,315
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Tumor Suppressor Phosphatases For Cancer Therapy
|
5U01CA141496-05
|
$746,599
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
7R01CA170549-02
|
$492,372
|
Panigrahy, Dipak
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Heme degradation pathway and immunomodulation in prostate cancer.
|
1R21CA169904-01A1
|
$227,070
|
Wegiel, Barbara
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SBIR Topic 314- High Content Screening of 3D Cultured Cancer Cells
|
N43CO130061-000
|
$285,423
|
ZAREMBINSKI, TOM
|
BIOTIME, INC.
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S3
|
$501,282
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S4
|
$122,789
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-23
|
$308,545
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Mechanisms of Action and Signaling by Steroid Hormone Antagonists
|
5R01CA101992-09
|
$237,315
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Angiogenin-induced RNA cleavage in cancer
|
1R01CA168872-01A1
|
$356,063
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hypogonadism and Pain Perception in Androgen-Deprived Men with Prostate Cancer
|
1R21CA171316-01A1
|
$243,852
|
Basaria, Shehzad
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Obesity increased cancer risk by NKT cell depletion (PQ1)
|
5R21CA170194-02
|
$172,456
|
EXLEY, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitiative MRI of prostate cancer as a biomarker and guide for treatment
|
5U01CA151261-04
|
$321,752
|
Fennessy, Fiona
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
1U24CA180918-01
|
$724,331
|
Kikinis, Ron
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|